BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18061526)

  • 1. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.
    Monteiro E; Varzim G; Pires AM; Teixeira M; Lopes C
    Cancer Detect Prev; 2004; 28(4):237-43. PubMed ID: 15350626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2006 Jul; 42(6):607-13. PubMed ID: 16488657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma.
    Zhang YJ; Chen SY; Chen CJ; Santella RM
    Mol Carcinog; 2002 Feb; 33(2):125-9. PubMed ID: 11813305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan.
    Tsai MH; Tsai CW; Tsou YA; Hua CH; Hsu CF; Bau DT
    Anticancer Res; 2011 Jan; 31(1):227-31. PubMed ID: 21273603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
    Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
    Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
    Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT
    Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
    In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
    Mishra R; Das BR
    Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
    Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
    Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
    Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
    Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
    Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21/ WAF1 and cyclin D1 variants and oral squamous cell carcinoma.
    Gomes CC; Drummond SN; Guimarães AL; Andrade CI; Mesquita RA; Gomez RS
    J Oral Pathol Med; 2008 Mar; 37(3):151-6. PubMed ID: 18251939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
    Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
    Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
    Uzawa N; Sonoda I; Myo K; Takahashi K; Miyamoto R; Amagasa T
    Cancer; 2007 Nov; 110(10):2230-9. PubMed ID: 17893905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma.
    Holley SL; Matthias C; Jahnke V; Fryer AA; Strange RC; Hoban PR
    Oral Oncol; 2005 Feb; 41(2):156-60. PubMed ID: 15695117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.